ID | 118574 |
著者 |
Fujita, Kazutoshi
Kindai University
Kimura, Go
Nippon Medical School
Tsuzuki, Toyonori
Aichi Medical University
Kato, Taigo
Osaka University
Banno, Eri
Kindai University
Kazama, Akira
Niigata University
Yamashita, Ryo
Shizuoka Cancer Center
Matsushita, Yuto
Hamamatsu University School of Medicine
Ishii, Daisuke
Kitasato University
Nakagawa, Yuki
Chugai Pharmaceutical Co., Ltd.
Fukuyama, Tamaki
Chugai Pharmaceutical Co., Ltd.
Sano, Fumikazu
Chugai Pharmaceutical Co., Ltd.
Kondo, Yukihiro
Nippon Medical School
Uemura, Hirotsugu
Kindai University
|
キーワード | TIME (tumor immune microenvironment)
synchronous
metachronous
mRCC (metastatic renal cell carcinoma)
PD-L1
immunophenotype
|
資料タイプ |
学術雑誌論文
|
抄録 | The association between the tumor immune microenvironment (TIME) of primary lesions and time to metastasis remains unknown. The aim of our retrospective study was to investigate the differences in the TIME of primary lesions based on time intervals to metastasis, mainly between the synchronous group (SG; metastasis within 3 months) and metachronous group (MG; metastasis after 3 months), and its association with clinicopathological parameters in patients with metastatic renal cell carcinoma (mRCC). SG showed more immunogenic feature of TIME (PD-L1 positivity, CD8+ TIL infiltration) and poor prognostic pathological features (WHO/ISUP grade 4, necrosis, lymphovascular invasion, infiltrative growth pattern, and sarcomatoid differentiation). In addition, we observed that the time to metastasis differed by TIME characteristics (PD-L1 status, immunophenotype), which were associated with the WHO/ISUP grade. The TIME of primary lesions could affect the time to metastasis.
|
抄録別表記 | Biological or immunological differences in primary lesions between synchronous and metachronous metastatic renal cell carcinoma (mRCC) have been reported. However, the association between the tumor immune microenvironment (TIME) of primary lesions and time to metastasis remains unknown. We investigated the differences in the TIME of primary lesions based on time intervals to metastasis, mainly between the synchronous group (SG; metastasis within 3 months) and metachronous group (MG; metastasis after 3 months), and its association with clinicopathological parameters in patients with mRCC. Overall, 568 patients treated first-line with vascular endothelial growth factor receptor inhibitors comprised the analysis population (SG: N = 307 [54.0%]; MG: N = 261 [46.0%]). SG had a higher proportion of patients with poor prognostic pathological feature tumors: WHO/ISUP grade 4, necrosis, lymphovascular invasion, infiltrative growth pattern, and sarcomatoid differentiation. Regarding the TIME, more immunogenic features were seen in SG than MG, with a higher PD-L1 positivity and a lower proportion of the desert phenotype. This is the first study to examine the differences in the TIME of primary lesions in patients with mRCC based on the time intervals to metastasis. The TIME of primary lesions could affect the time to metastasis.
|
掲載誌名 |
Cancers
|
ISSN | 20726694
|
出版者 | MDPI
|
巻 | 14
|
号 | 21
|
開始ページ | 5258
|
発行日 | 2022-10-26
|
権利情報 | This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
|
EDB ID | |
出版社版DOI | |
出版社版URL | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
出版社版
|
部局 |
医学系
|